0001104659-17-025476.txt : 20170424 0001104659-17-025476.hdr.sgml : 20170424 20170424164723 ACCESSION NUMBER: 0001104659-17-025476 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170424 FILED AS OF DATE: 20170424 DATE AS OF CHANGE: 20170424 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001356576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 1550 E GUDE DR CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-838-2500 MAIL ADDRESS: STREET 1: 1550 E GUDE DR CITY: ROCKVILLE STATE: MD ZIP: 20850 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bhatt Padmanabh P. CENTRAL INDEX KEY: 0001539215 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35518 FILM NUMBER: 17778701 MAIL ADDRESS: STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC. STREET 2: 1550 EAST GUDE DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 a4.xml 4 X0306 4 2017-04-24 0 0001356576 SUPERNUS PHARMACEUTICALS INC SUPN 0001539215 Bhatt Padmanabh P. C/O SUPERNUS PHARMACEUTICALS, INC. 1550 EAST GUDE DRIVE ROCKVILLE MD 20850 0 1 0 0 Sr. VP of IP, CSO Common Stock 2017-04-24 4 S 0 11806 32.5904 D 45500 D Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 24, 2017. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.3250 to $32.6750, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. /s/ Gregory S. Patrick, as attorney-in-fact 2017-04-24